We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Why it's important to evaluate digital health products that have been developed rapidly and how to choose evaluation methods in these circumstances.
Tables of the indicators included in Local Health data updates.
Personal statements from new award holders in the Advisory Committee on Clinical Excellence Awards (ACCEA) 2017 rounds.
ACCEA has announced the results of the 2016 round of the clinical excellence awards for England and Wales.
Executive summary of quality assurance (QA) visit to Bristol, Bath and Weston abdominal aortic aneurysm screening programme held on 6 July 2016.
Executive summary of quality assurance (QA) visit to Sandwell and West Birmingham Hospitals NHS Trust cervical screening programme on 27 April 2017.
Advice and guidance on the health needs of migrant patients from Uganda for healthcare practitioners.
The role of patient and public voice (PPV) members on the UK National Screening Committee (UK NSC)
This treaty was presented to Parliament in April 2018.
Information and procedural guidance on SSBBV testing.
The five nations meetings provide a forum for discussion, debate and collaboration for health and justice partners.
UK government interpretation of the requirements for labelling e-liquids for Northern Ireland.
The types of emissions a manufacturer or importer of e-cigarettes should notify us about.
Executive summary of quality assurance (QA) visit to North West London Diabetic Eye Screening Programme held on 8 February 2017.
This publication (Documents of the NRPB volume 12 number 3) contains the recommendations of the Second UK Working Group on stable iodine prophylaxis.
Outlines how PHE manage the NDA epidemiology programme to check if current guidelines provide adequate protection for UK radiation workers.
Executive summary of quality assurance (QA) visit to Carcroft Health Centre held on 21 July 2017.
Information for UK and EU organisations about existing and future funding.
A guidance statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).
Guidance for when a person with diabetes chooses to be screened by a different diabetic eye screening (DES) service from the one their GP is linked to.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).